HeartBeam (BEAT) Short term Debt (2020 - 2021)
HeartBeam's (BEAT) quarterly Short term Debt came in at $5.4 million in Q3 2021, up 26.17% quarter-over-quarter from $4.3 million in Q4 2020.
Powered by 
Analysis
HeartBeam (BEAT) Short term Debt (2020 - 2021) Analysis & Trends
HeartBeam (BEAT) has reported Short term Debt for 2 consecutive years, with $5.4 million the latest figure, recorded in Q3 2021.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $5.4 million in Q3 2021; TTM through Sep 2021 was $5.4 million, a N/A change from a year earlier, with the FY2020 full-year figure at $4.3 million, changed N/A from the prior year.
- Short term Debt was $5.4 million for Q3 2021 at HeartBeam, up from $4.3 million in the prior quarter.
- Over five years, Short term Debt peaked at $5.4 million in Q3 2021 and troughed at $4.3 million in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | HeartBeam | 24.23 Mn | 24.23 Mn | - |